Stories about research and scientific development at Mount Sinai
Advances in Heart Failure Research and Clinical Care
Mount Sinai scientists and clinicians are making notable advances in the study and treatment of heart failure, a common condition that occurs when the heart becomes too weak to pump and circulate enough blood through the body. Diseases that damage the heart—such as...
Exploring Diverse Microbes Among Remote Amerindians
A population of Amerindian hunter-gatherers, who until recently had lived in isolation in the remote Venezuelan Amazon, is yielding a trove of information for scientists at Mount Sinai who are studying their microbiome and finding the most diverse levels of bacteria...
Clinical Trial Reveals Benefits of Peanut Allergy Skin Patch
Mount Sinai researchers—leading the largest clinical trial on peanut allergy desensitization—have concluded that a skin patch that gradually exposes the body to small amounts of peanut allergen appears to be safe and effective, and holds promise as a potential...
Study Reveals Mechanisms that Activate Depression
New research at the Icahn School of Medicine at Mount Sinai sheds light for the first time on how depression and emotional resilience operate on a molecular level. The findings, published in the December 4, 2014, issue of Nature, bring fresh perspective to an area...
Uncovering a Stronger Link Between Obesity and Genes
Researchers from Icahn School of Medicine at Mount Sinai, participating in the largest genetic study yet on obesity, have helped uncover stronger links between genes and body weight and body fat distribution. The trailblazing discoveries were published in two...
Restorative Surgery That Patients Can Smile About
Joshua D. Rosenberg, MD, Assistant Professor of Otolaryngology at Icahn School of Medicine at Mount Sinai, is one of only a handful of U.S. surgeons who is using an innovative new procedure to restore the ability to smile in patients with facial paralysis. The...
Repurposing a Drug to Prevent and Treat Cancers
Two studies published recently in the Proceedings of the National Academy of Sciences, led by researchers at the Icahn School of Medicine at Mount Sinai, demonstrate how widely used, inexpensive medications to treat osteoporosis, known as bisphosphonates, have the...
Forbes Honors Pioneering Neurosurgery Resident
Eric Oermann, MD, a pioneering Neurosurgery second-year resident at Icahn School of Medicine at Mount Sinai, has been named to the fourth annual Forbes “30 Under 30” list as one of the nation’s top Health Care innovators for 2015. According to Forbes, the honorees...
New Discoveries in the Treatment of Eczema
Seminal research led by Emma Guttman-Yassky, MD, Associate Professor of Dermatology, and Medicine (Clinical Immunology), at Icahn School of Medicine at Mount Sinai, has identified the key drivers of eczema and given rise to promising new treatments that appear to...